February 2024 SOCRA Source Journal - Journal - Page 61
REFERENCES
51. Efficacy and safety study of ABP 980 compared with Trastuzumab in women with HER2-positive early
breast cancer. Accessed May 22, 2022. https://www.clinicaltrials.gov/ct2/show/results/NCT01901146.
52. A study of biweekly Gemcitabine, Paclitaxel, and Avastin in patients with metastatic breast cancer.
Accessed May 22, 2022. https://www.clinicaltrials.gov/ct2/show/study/NCT00618826.
53. Fanaroff A, Li S, Webb L, et al. An observational study of the association of video- vs. text-based
informed consent with multicenter trial enrollment: Lessons from the PALM Study. Circ Cardiovasc Qual
Outcomes. 2018;11(4):e004675. doi:10.1161/CIRCOUTCOMES.118.004675
54. Single-arm Phase II etudy of NDURE for patients with HNC. https://www.clinicaltrials.gov/ct2/show/
NCT03821064. Accessed May 22, 2022.
55. Navigation for timely adjuvant therapy for patients with locally advanced HNSCC. https://www.
clinicaltrials.gov/ct2/show/NCT04098458. Accessed May 22, 2022.
56. A study in the United States using electronic medical records (EMR) to assess effectiveness of Afatinib
(Gilotrif) following Pembrolizumab and chemotherapy in the treatment of metastatic squamous cell
carcinoma of the lung. Accessed July 7, 2022. https://www.clinicaltrials.gov/ct2/show/results/NCT04552535.
57. Nystuen P, Hagen KB. Telephone reminders are effective in recruiting nonresponding patients to
randomized controlled trials. J Clin Epidemiol. 2004;57(8):773–776. doi:10.1016/j.jclinepi.2003.12.015
58. TrialSpark. Trialspark and Sanofi announce collaboration to accelerate COPD clinical development.
https://www.prnewswire.com/news-releases/trialspark-and-sanofi-announce-collaboration-to-acceleratecopd-clinical-development-301299386.html. Published May 26, 2021. Accessed November 10, 2021.
59. Myshko D. PharmaVOICE. Addressing diversity in clinical trials. https://www.pharmavoice.com/
article/2018-03-diversity/. Published March, 2018. Accessed November 10, 2021.
60. Advancing clinical trials. Genentech. https://www.gene.com/stories/advancing-clinical-trials. Published
January 8, 2021. Accessed November 12, 2021.
61. FDA takes important steps to increase racial and ethnic diversity in clinical trials. US Food & Drug
Administration. https://www.fda.gov/news-events/press-announcements/fda-takes-important-steps-increaseracial-and-ethnic-diversity-clinical-trials. Accessed July 7th, 2022.
62. Lung cancer screening decisions - tabular view. Lung Cancer Screening Decisions - Tabular View ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/record/NCT02899754. Accessed November 12, 2021.
63. Schapira M, Chhatre S, Prigge J, et al. JMIR Form Res. 2022; 6(4):e290039. doi:10.2196/29039
64. COVID-19 and health disparities: the impact on black/African Americans. IDSA. https://www.idsociety.
org/globalassets/idsa/public-health/covid-19/covid-and-african-americans-policy-brief-final.pdf. Published
June 2020. Accessed November 10, 2021.
SOCRA SOURCE © May 2023
61